ProBioGen announced today an agreement with Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars. Under this agreement ProBioGen will conduct high-performance cell line development services for Polpharma’s biosimilar candidate, supporting their expanding pipeline. The biologics industry mantra ‘the process defines the product,’ underscores the importance of starting with the […]
Post Type Archives: News
Univercells Technologies Debuts the scale-X™ Nitro Controller to Expand Access to Large-Scale Viral and Advanced Therapy Manufacturing
Univercells Technologies, a Donaldson Life Sciences company and global provider of bioprocessing solutions, announced the launch of the scale-X™ nitro controller, the latest addition to its scale-X fixed-bed bioreactor portfolio. Designed to operate both the 200 and 600 m² scale-X nitro bioreactors, the new controller, as part of the scale-X platform, offers a cost-effective, low-footprint […]
Almac Discovery and Formosa Pharmaceuticals announce global licensing agreement for development and commercialisation of ALM-401, a first-in-class EGFRxROR1 Bispecific Antibody-Drug Conjugate
Formosa Pharmaceuticals, Inc. (“Formosa”; 6838.TW ticker-symbol on the Taiwan Stock Exchange) and Almac Discovery announce a global licensing agreement for development and commercialisation of ALM-401, a first-in-class engineered bispecific Antibody-Drug Conjugate (ADC), addressing the high unmet needs of cancer patients worldwide suffering with intractable and aggressive solid tumours. The agreement facilitates the next phases of […]
Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer
Hovione, an international integrated pharmaceutical development and manufacturing organization, and Firstgene Life Sciences, a portfolio company of the Swiss incubator Xlife Sciences AG (SIX:XLS), today announced a strategic collaboration to advance Hovione’s proprietary virus-like particle drug delivery platform for the targeted treatment of Hepatocellular Carcinoma (HCC), a therapeutic indication developed by Firstgene. Under the terms […]
Andelyn Biosciences Applies the AAV Curator® Platform to Deliver Novel Gene Therapy for an Ultra-Rare NEDAMSS Disease Patient 14-Months after Diagnosis
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has successfully manufactured a novel viral vector gene therapy with its AAV Curator® Platform to treat a baby with the ultra-rare disease Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech, and Seizures (NEDAMSS). This is a major […]
Almac Diagnostic Services launches PNPLA3 Genotyping Kit for Liver Disease Research
Almac kit will assist researchers with further insights into MASH / MASLD biology Almac Diagnostic Services, a member of the Almac Group, has today announced the launch of a new PNPLA3 genotyping kit for liver disease research. This novel kit provides accurate genotyping of the PNPLA3 gene within a simple workflow, providing researchers with further […]
Bespak achieves sustainability milestone with first life cycle assessment for pressurised Metered Dose Inhaler valve
Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), today announced that it has completed its first life cycle assessment (LCA) for its market-leading BK357 pressurised Metered Dose Inhaler (pMDI) valve. This important step comes as a result of Bespak’s commitment to looking beyond low Global Warming Potential (GWP) propellants for opportunities to reduce […]
Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing Capacity
Symbiosis Pharmaceutical Services (Symbiosis), a global sterile fill/finish contract manufacturing organisation (CMO) has successfully completed its latest audit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), following an inspection of its new GMP manufacturing facility. The inspection assessed the company’s new purpose-built Bruce Building, a 20,000 sq ft aseptic facility housing an automated […]
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics
Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to Investigational New Drug (IND) filing from 13 to nine months, helping biotech and pharmaceutical companies overcome logistical complexities within pre-clinical biologic drug development. The new CHO K-1 cell […]
Merck Group to Acquire US Biopharma Company SpringWorks Therapeutics
Merck, a leading science and technology company, and SpringWorks Therapeutics, Inc., a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the companies have entered into a definitive agreement for Merck to acquire SpringWorks. The purchase price of $47 per share in cash represents an equity value of approximately $3.9 […]